• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非随机治疗分配和相依删失情况下的双稳健加权对数秩检验及雷尼型检验。

Doubly robust weighted log-rank tests and Renyi-type tests under non-random treatment assignment and dependent censoring.

作者信息

Li Chenxi

机构信息

Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA.

出版信息

Stat Methods Med Res. 2019 Sep;28(9):2649-2664. doi: 10.1177/0962280218785926. Epub 2018 Jul 9.

DOI:10.1177/0962280218785926
PMID:29984622
Abstract

The log-rank test is widely used to test difference in event time distribution between treatment groups. However, if subjects are not randomly assigned to treatment groups, which is often the case in observation studies, the log-rank test is not asymptotically correct for detecting group survival difference due to the imbalance of confounding variables between groups. We develop a class of modified weighted log-rank tests and Renyi-type tests for two-sample survival comparison under non-random treatment assignment. The new tests can also account for non-random censoring that depends on baseline covariates. The proposed methods involve building working models for treatment assignment, cause-specific hazard of dependent censoring, and the time to event. We prove that, when either the models for treatment assignment and dependent censoring or the model for the event time is true, the new tests are asymptotically correct, i.e. being doubly robust. Numerical experiments demonstrate the tests' double-robustness property in finite samples of realistic sizes, and also show that the doubly robust log-rank test is at least as powerful as the regular log-rank test when the treatment assignment is random and there is no dependent censoring. An application to a kidney transplant data set illustrates the utility of the proposed methods.

摘要

对数秩检验被广泛用于检验治疗组之间事件时间分布的差异。然而,如果受试者不是随机分配到治疗组,而这在观察性研究中经常出现,由于组间混杂变量的不平衡,对数秩检验在检测组间生存差异时渐近不正确。我们开发了一类修正的加权对数秩检验和Renyi型检验,用于在非随机治疗分配下的两样本生存比较。新的检验还可以考虑依赖于基线协变量的非随机删失。所提出的方法涉及构建治疗分配、依赖删失的特定病因风险以及事件发生时间的工作模型。我们证明,当治疗分配和依赖删失的模型或事件时间的模型正确时,新的检验是渐近正确的,即具有双重稳健性。数值实验证明了检验在实际大小的有限样本中的双重稳健性,并且还表明,当治疗分配是随机的且不存在依赖删失时,双重稳健对数秩检验至少与常规对数秩检验一样有效。对一个肾移植数据集的应用说明了所提出方法的实用性。

相似文献

1
Doubly robust weighted log-rank tests and Renyi-type tests under non-random treatment assignment and dependent censoring.非随机治疗分配和相依删失情况下的双稳健加权对数秩检验及雷尼型检验。
Stat Methods Med Res. 2019 Sep;28(9):2649-2664. doi: 10.1177/0962280218785926. Epub 2018 Jul 9.
2
Two-sample tests for survival data from observational studies.观察性研究中生存数据的双样本检验。
Lifetime Data Anal. 2018 Jul;24(3):509-531. doi: 10.1007/s10985-017-9408-1. Epub 2017 Aug 28.
3
Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.存在与时间相关的协变量的删失依赖性下风险的双重稳健估计:普伐他汀治疗冠心病一级预防试验的应用。
BMC Med Res Methodol. 2020 Jul 31;20(1):204. doi: 10.1186/s12874-020-01087-8.
4
Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.生存结局临床试验中使用适应性加权对数秩检验的期中监测。
Stat Med. 2019 Feb 20;38(4):601-612. doi: 10.1002/sim.7958. Epub 2018 Sep 12.
5
Nonparametric comparison of two survival-time distributions in the presence of dependent censoring.存在相依删失情况下两个生存时间分布的非参数比较。
Biometrics. 2003 Sep;59(3):497-504. doi: 10.1111/1541-0420.00059.
6
Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies.观察性研究中受限平均寿命差异的双稳健半参数估计量。
Biometrics. 2012 Dec;68(4):999-1009. doi: 10.1111/j.1541-0420.2012.01759.x. Epub 2012 Apr 4.
7
Weighted log-rank test to compare two survival functions in the presence of dependent censoring.在存在相依删失的情况下比较两个生存函数的加权对数秩检验。
Pharm Stat. 2022 Nov;21(6):1281-1293. doi: 10.1002/pst.2245. Epub 2022 Jun 16.
8
An analytic method for randomized trials with informative censoring: Part II.具有信息性截尾的随机试验的一种分析方法:第二部分。
Lifetime Data Anal. 1995;1(4):417-34. doi: 10.1007/BF00985453.
9
An analytic method for randomized trials with informative censoring: Part 1.一种针对具有信息性截尾的随机试验的分析方法:第1部分。
Lifetime Data Anal. 1995;1(3):241-54. doi: 10.1007/BF00985759.
10
Sequential tests for non-proportional hazards data.非比例风险数据的序贯检验。
Lifetime Data Anal. 2017 Jul;23(3):339-352. doi: 10.1007/s10985-016-9360-5. Epub 2016 Mar 11.

引用本文的文献

1
Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma.用于预测Ⅰ期子宫内膜癌进展和预后的五基因特征识别
Oncol Lett. 2020 Sep;20(3):2396-2410. doi: 10.3892/ol.2020.11798. Epub 2020 Jul 1.